urothelium carcinoma and cervical cancer
Conditions
Interventions
Sponsors
First Medical Center, PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: Subjects who met all the following criteria can be included in this study : 1. Informed consent must be obtained before participating in the study ; 2, 18 years old = 1.5 × 10 ^ 9 / L, platelet count > = 90 × 10 ^ 9 / L, hemoglobin > = 90 g / L ; liver : total bilirubin ( TBIL ) < = 1.5 times upper limit of normal ( ULN ), alanine aminotransferase ( ALT ) and aspartate aminotransferase ( AST ) < = 3.0 × ULN ; kidney : serum creatinine ( SCr ) < = 1.5 × ULN.
Exclusion criteria
Exclusion criteria: Subjects who meet the following exclusion criteria are not permitted to enter this study : 1. Patients or researchers who are unable to accept PET examination due to weight, claustrophobia, radiation phobia, inability to lie for a long time during the examination, etc., determine that the patient has any situation that cannot cooperate with the imaging examination and operation ; 2, 4 weeks received previous chemotherapy, radiotherapy, targeted therapy or other anti-tumor therapy ( except anti-cancer Chinese medicine treatment ) ; 3.Patients with central nervous system ( CNS ) metastasis who have symptoms or are receiving glucocorticoid therapy ; 4.Patients with a history of other malignant tumors ( except for patients who had undergone radical treatment and had been treated for more than 3 years before enrollment and had no evidence of recurrence / metastasis ) ; 5. Complicated with serious or poorly controlled medical diseases, including, but not limited to, uncontrollable infections, hypertension, acute coronary syndrome, or other diseases that researchers believe may affect the study ; 6. Those who are allergic to the study of drugs and their components ; 7.In the 7 days before the study drug injection, the female blood pregnancy test was positive ; 8.Patients who did not agree to take effective contraceptive measures or restrictive behaviors during the study period and 4 weeks after administration ; 9. Lactating women ; 10.There are other conditions that researchers believe are not suitable for the experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum Standard Uptake Value,SUV max; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity, SE;Specificity, SP;Positive predicative value, PPV; | — |
Countries
China
Contacts
Public ContactJinming Zhang
First Medical Center, PLA General Hospital
Outcome results
None listed